Market Cap 500.95M
Revenue (ttm) 0.00
Net Income (ttm) -21.61M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 2,007,300
Avg Vol 892,232
Day's Range N/A - N/A
Shares Out 52.96M
Stochastic %K 7%
Beta 0.25
Analysts Strong Sell
Price Target $16.33

Company Profile

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was in...

Industry: Biotechnology
Sector: Healthcare
Phone: 310 651 8041
Address:
11400 West Olympic Boulevard, Suite 200, Los Angeles, United States
Uncle_Baby_Billy
Uncle_Baby_Billy Mar. 21 at 3:24 PM
$IMMX Don’t see where the earnings date was released by the company, but keep seeing suggestions that it’s this coming Monday morning. Can anyone confirm that? Thanks in advance!
0 · Reply
TurningAProfit
TurningAProfit Mar. 21 at 1:31 PM
0 · Reply
Whathehelly
Whathehelly Mar. 21 at 1:31 AM
0 · Reply
Mungermind
Mungermind Mar. 20 at 9:31 PM
$IMMX Israel Englander increased his stake to nearly 3mm. SEC disclosure filed today after hours.
0 · Reply
TonyLA
TonyLA Mar. 20 at 9:12 PM
$IMMX Still very stinky.
0 · Reply
ReCaster
ReCaster Mar. 20 at 9:04 PM
$IMMX short right about now
0 · Reply
ReCaster
ReCaster Mar. 20 at 8:59 PM
$IMMX So new 13G, Millennium Management LLC added 1,152,452 new shares since reporting on 13F 2/17. There goes those shares from the retail pool! https://s3.amazonaws.com/sec.irpass.cc/2649/0001104659-26-032741.htm
0 · Reply
ImmxBeliever
ImmxBeliever Mar. 20 at 8:55 PM
$IMMX 🚨 IMMX OWNERSHIP ALERT — THE FLOAT IS GETTING LOCKED 🚨 Three separate Schedule 13G filings now show major funds crossing the 5% disclosure threshold in $IMMX. Here’s what’s now PUBLIC: • Janus Henderson — 7.4% (3,921,568 shares) • Saturn V Capital — 6.97% (3,693,585 shares) • Millennium Management — 5.3% (2,812,230 shares) That’s ~10.4 MILLION SHARES disclosed by just three institutions. Combined ownership: ~19–20% of the entire company. And remember: These are only the holders required to disclose because they crossed 5%. Translation: 🔒 A large portion of the float is now sitting in institutional hands. 📄 Each one had to file with the SEC once they crossed the threshold. 🐋 Millennium alone manages $60B+ and just planted a 5% flag. Small-float biotech + institutional accumulation + catalysts on deck = volatility. Follow the filings. $IMMX
1 · Reply
ImmxBeliever
ImmxBeliever Mar. 20 at 8:51 PM
$IMMX 🚨 BREAKING — MILLENNIUM MANAGEMENT FILES 13G ON IMMX 🚨 Just dropped today. Millennium Management (Israel Englander’s $60B+ hedge fund) just filed a 13G showing 5.3% ownership of $IMMX. 2,812,230 shares. That’s not retail. That’s not a tourist position. That’s a top-tier institutional quant fund planting a flag. Key points: • Event date: March 13 • Filed: March 20 • Ownership: 5.3% Translation: they crossed the 5% reporting threshold, which triggers an SEC filing. Funds like Millennium run massive data pipelines across biotech catalysts. They don’t randomly accumulate millions of shares in a tiny float biotech. Something clearly caught their models. Now layer this with: • RMAT-designated NXC-201 • BLA path in play • Multiple institutional holders already building positions • Micro float If additional funds start crossing the 5% disclosure line, the float could tighten very fast. Today’s filing is a signal. Let’s see who shows up next. $IMMX
0 · Reply
Mungermind
Mungermind Mar. 20 at 8:02 PM
$IMMX A few points: 1. The stock rose very quickly. Traders will enter and exit. Investors that understand the therapy know it was just a delayed repricing to move the stock to where it should be (many of its peers trade in a similar range of 500-700mm [KYTX, LYEL, AUTOL]. 2. The rapid rise and the challenging macro makes this an obvious target for algorithmic shorting. I WANT this to be massively shorted. The float is so thin. Any half-witted person must realize that this drug will get approval even if the CR rate drops of 50%. There is no other approved option and the competitors are still much further away. It will absolutely explode higher when the data is released. 3. Not a single insider has sold a single share ever
1 · Reply
Latest News on IMMX
Immix Biopharma: I Am Surprised To Reaffirm A 'Buy'

Nov 6, 2025, 2:39 PM EST - 4 months ago

Immix Biopharma: I Am Surprised To Reaffirm A 'Buy'


Immix Biopharma Announces Other Serious Diseases Strategy

Aug 6, 2025, 12:30 PM EDT - 8 months ago

Immix Biopharma Announces Other Serious Diseases Strategy


Immix Biopharma Attends FDA CEO Forum in Washington DC

Jun 6, 2025, 9:39 AM EDT - 10 months ago

Immix Biopharma Attends FDA CEO Forum in Washington DC


Immix Biopharma 12 Month Review Progress Update

Feb 21, 2024, 9:31 AM EST - 2 years ago

Immix Biopharma 12 Month Review Progress Update


Uncle_Baby_Billy
Uncle_Baby_Billy Mar. 21 at 3:24 PM
$IMMX Don’t see where the earnings date was released by the company, but keep seeing suggestions that it’s this coming Monday morning. Can anyone confirm that? Thanks in advance!
0 · Reply
TurningAProfit
TurningAProfit Mar. 21 at 1:31 PM
0 · Reply
Whathehelly
Whathehelly Mar. 21 at 1:31 AM
0 · Reply
Mungermind
Mungermind Mar. 20 at 9:31 PM
$IMMX Israel Englander increased his stake to nearly 3mm. SEC disclosure filed today after hours.
0 · Reply
TonyLA
TonyLA Mar. 20 at 9:12 PM
$IMMX Still very stinky.
0 · Reply
ReCaster
ReCaster Mar. 20 at 9:04 PM
$IMMX short right about now
0 · Reply
ReCaster
ReCaster Mar. 20 at 8:59 PM
$IMMX So new 13G, Millennium Management LLC added 1,152,452 new shares since reporting on 13F 2/17. There goes those shares from the retail pool! https://s3.amazonaws.com/sec.irpass.cc/2649/0001104659-26-032741.htm
0 · Reply
ImmxBeliever
ImmxBeliever Mar. 20 at 8:55 PM
$IMMX 🚨 IMMX OWNERSHIP ALERT — THE FLOAT IS GETTING LOCKED 🚨 Three separate Schedule 13G filings now show major funds crossing the 5% disclosure threshold in $IMMX. Here’s what’s now PUBLIC: • Janus Henderson — 7.4% (3,921,568 shares) • Saturn V Capital — 6.97% (3,693,585 shares) • Millennium Management — 5.3% (2,812,230 shares) That’s ~10.4 MILLION SHARES disclosed by just three institutions. Combined ownership: ~19–20% of the entire company. And remember: These are only the holders required to disclose because they crossed 5%. Translation: 🔒 A large portion of the float is now sitting in institutional hands. 📄 Each one had to file with the SEC once they crossed the threshold. 🐋 Millennium alone manages $60B+ and just planted a 5% flag. Small-float biotech + institutional accumulation + catalysts on deck = volatility. Follow the filings. $IMMX
1 · Reply
ImmxBeliever
ImmxBeliever Mar. 20 at 8:51 PM
$IMMX 🚨 BREAKING — MILLENNIUM MANAGEMENT FILES 13G ON IMMX 🚨 Just dropped today. Millennium Management (Israel Englander’s $60B+ hedge fund) just filed a 13G showing 5.3% ownership of $IMMX. 2,812,230 shares. That’s not retail. That’s not a tourist position. That’s a top-tier institutional quant fund planting a flag. Key points: • Event date: March 13 • Filed: March 20 • Ownership: 5.3% Translation: they crossed the 5% reporting threshold, which triggers an SEC filing. Funds like Millennium run massive data pipelines across biotech catalysts. They don’t randomly accumulate millions of shares in a tiny float biotech. Something clearly caught their models. Now layer this with: • RMAT-designated NXC-201 • BLA path in play • Multiple institutional holders already building positions • Micro float If additional funds start crossing the 5% disclosure line, the float could tighten very fast. Today’s filing is a signal. Let’s see who shows up next. $IMMX
0 · Reply
Mungermind
Mungermind Mar. 20 at 8:02 PM
$IMMX A few points: 1. The stock rose very quickly. Traders will enter and exit. Investors that understand the therapy know it was just a delayed repricing to move the stock to where it should be (many of its peers trade in a similar range of 500-700mm [KYTX, LYEL, AUTOL]. 2. The rapid rise and the challenging macro makes this an obvious target for algorithmic shorting. I WANT this to be massively shorted. The float is so thin. Any half-witted person must realize that this drug will get approval even if the CR rate drops of 50%. There is no other approved option and the competitors are still much further away. It will absolutely explode higher when the data is released. 3. Not a single insider has sold a single share ever
1 · Reply
ReCaster
ReCaster Mar. 20 at 7:26 PM
2 · Reply
Naturallaws
Naturallaws Mar. 20 at 6:32 PM
$IMMX i think, but am not certain, that Immix filed for a shelf registration, which means they reserve the right for future dilution. I have only one source and am not confident it is entirely correct, so double check before taking this as fact.
2 · Reply
Loaf_of_Brade
Loaf_of_Brade Mar. 20 at 5:00 PM
$IMMX could sell of be possible fear for earning on Monday?
1 · Reply
elmono
elmono Mar. 20 at 3:11 PM
$IMMX when the dip keeps dipping…minus 20% in a few days…..so much room to go more
0 · Reply
elmono
elmono Mar. 20 at 3:08 PM
$IMMX what a POS….back to 5
0 · Reply
Loaf_of_Brade
Loaf_of_Brade Mar. 20 at 2:21 PM
$IMMX how far down will it go?
1 · Reply
Whathehelly
Whathehelly Mar. 20 at 1:31 PM
0 · Reply
DragonAlgo
DragonAlgo Mar. 20 at 6:13 AM
🐉 $IMMX CALL — DragonAlgo® Signal Contract: IMMX CALL Expiry: 2026-04-17 | Strike: $10.00 | Type: CALL Option Plan (premium): Entry: $1.45 Stop: $1.04 TP1: $1.89 TP2: $2.46 TP3: $3.48 Active momentum environment. 🔗 https://dragonalgo.com
0 · Reply
Mother_Nature
Mother_Nature Mar. 20 at 1:31 AM
0 · Reply
Dingalingading
Dingalingading Mar. 20 at 12:38 AM
$IMMX I needed a reset also Core trading lessons to remind myself... A vertical spike never replaces a structural reset. vertical spikes on thin orders are not real support. Chasing price is a bad habit. Let it come to you. Don’t just jump in or out at a certain price. Let it drop or rise until it stops. It always retests the bottom and top. Structural trading > emotional trading. Good luck out there!
0 · Reply
Oz86
Oz86 Mar. 19 at 4:59 PM
$IMMX get ready for liftoff this month boyzzz
1 · Reply
Isitreallyhim
Isitreallyhim Mar. 19 at 1:39 PM
$IMMX Sushi is liquidating ....get out now if you can
1 · Reply